Trial Information

Summary: A phase III double-blind study which will evaluate the safety and efficacy of two doses of investigational drug compared to Valsartan in subjects with Essential Hypertension

Physicians from Cherry Hill Internal Medicine are currently conducting a research study for people with high blood pressure. This study compares the effectiveness and safety of TAK-491, an investigational medication, and valsartan in the treatment of hypertension. We are excited about this opportunity and invite your participation. This study lasts approximately 7 months and includes 14 visits, with up to 4 additional visits depending on test results. You will receive thorough research-related medical attention and testing at no cost. During the study, you will be provided with study medication. In addition, you will be compensated for participating in the study. Through participation in research you may learn more about your own health and contribute to medical research in finding future new treatments for hypertension.

You MAY be eligible to participate if you can answer YES to the following questions:

• Are you generally healthy with a diagnosis of high blood pressure?
• Are you 18 years of age or older?

Patient Exclusion Criteria:

• Have had a heart attack or stroke in the last 6 months?
• Have had cancer in the past 5 years (except basal cell)?
• Have diabetes (Type I - insulin dependent)

If you would like to learn more about participating in this study, please send an e-mail message using the form below.